Bibliography
Found 91 results
Filters: Author is Letendre, Scott [Clear All Filters]
Proteomic fingerprints in CSF and blood of HIV-infected patients with neurocognitive disorders. In: The 9th International Symposium on NeuroVirology. The 9th International Symposium on NeuroVirology. Miami Beach, FL; 2009.
The relationship between levels of CD4+ counts and HIV-1 RNA in CSF and plasma in 900 samples. In: Eighth Conference on Retroviruses and Opportunistic Infections. Eighth Conference on Retroviruses and Opportunistic Infections. ; 2001.
. Validation of post-mortem CSF viral load by comparison to ante-mortem viral load and clinical measurements. In: Journal of NeuroVirology. Vol. 9. Journal of NeuroVirology. ; 2003. p. 130.
. Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation. J Acquir Immune Defic Syndr. 2015 ;68(3):281-8.
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 ;84(3):241-50.
Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. Journal of NeuroVirology [Internet]. 2013 ;19(1):89-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23341224
Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology [Internet]. 2013 ;8(5):1197-1209. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24292993
. Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals. J Neurovirol. 2016 ;22(5):607-614.
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.
Association of Plasma Eicosanoid Levels With Immune, Viral, and Cognitive Outcomes in People With HIV. Neurology. 2022 ;99(12):e1251-e1264.
. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.
Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2019 ;82(5):475-482.
. Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology. J Infect Dis. 2023 ;227(Suppl 1):S3-S15.
. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. Journal of NeuroVirology [Internet]. 2005 ;11(4):356-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16206458
Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2020 ;83(1):56-64.
. Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy. AIDS. 2019 ;33(10):1575-1582.
. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. Journal of Neuroimmunology [Internet]. 2004 ;157(1-2):185-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15579296
. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 ;25(14):1747-51.
Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. J Neuroinflammation. 2017 ;14(1):72.
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.
Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathology (Zurich, Switzerland) [Internet]. 2003 ;13(2):195-210. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12744473
. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of Neurovirology [Internet]. 2009 ;15:360-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20175693
Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus-Infected Patients. J Acquir Immune Defic Syndr. 2019 ;82(1):61-70.
. A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning. J Neurovirol. 2018 ;24(5):549-556.
. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. Journal of the International Neuropsychological Society: JINS [Internet]. 2003 ;9(1):64-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12570359